Question 1

How does Artemisia argyi work for menstrual regulation?

Accepted Answer

Artemisia argyi contains active compounds including thujone, cineole, borneol, and flavonoids that contribute to its therapeutic effects. In traditional Chinese medicine, it is classified as a warming herb that promotes blood circulation and helps regulate menstrual cycles. The volatile oils may stimulate uterine smooth muscle, while flavonoids provide anti-inflammatory support. Its hemostatic properties help manage excessive menstrual bleeding. Evidence for these mechanisms is rated Level C, based primarily on traditional use and preliminary pharmacological studies rather than robust clinical trials.

Question 2

Does Chinese mugwort interact with any medications?

Accepted Answer

Artemisia argyi may interact with medications metabolized by the liver, as thujone content can potentially stress hepatic function. Patients taking anticoagulants or antiplatelet drugs should exercise caution due to the herb's effects on blood circulation. Those on hormone therapies should consult healthcare providers, as mugwort may influence menstrual cycles. Individuals with liver disease or taking hepatotoxic medications should avoid internal use. Evidence for specific drug interactions is limited (Level C), warranting healthcare provider consultation before combining with prescription medications.

Question 3

What is the recommended dosage for Artemisia argyi?

Accepted Answer

The traditional adult dosage for Artemisia argyi is 3-9 grams of dried herb prepared as a tea or decoction. For moxibustion therapy, dried mugwort is formed into cones or sticks and burned near specific acupuncture points. Internal use should not exceed recommended amounts due to potential thujone toxicity. Dosage recommendations are based on traditional use (Level C evidence) rather than standardized clinical trials. Always consult a qualified TCM practitioner for personalized dosing guidance.

Question 4

Is Artemisia argyi safe during pregnancy?

Accepted Answer

Artemisia argyi is contraindicated during pregnancy and is considered unsafe for pregnant women. As an emmenagogue, it stimulates uterine contractions and blood flow to the pelvic region, which may increase the risk of miscarriage or premature labor. Both internal use and moxibustion should be avoided throughout pregnancy. Women who are breastfeeding should also exercise caution, as safety data is limited. This safety concern is well-documented in traditional Chinese medicine texts and supported by the herb's physiological effects on uterine tissue.

Question 5

What are the side effects of Chinese mugwort?

Accepted Answer

Common side effects of Artemisia argyi include allergic skin reactions with topical use and respiratory irritation from moxibustion smoke inhalation. Internal overdose can cause liver toxicity due to thujone content, with symptoms including nausea, dizziness, and in severe cases, seizures. Long-term excessive use may result in cumulative liver damage. Individuals with pre-existing liver conditions should avoid internal use entirely. Smoke from moxibustion may aggravate asthma or respiratory conditions. Evidence for these adverse effects is rated Level C, based on case reports and pharmacological understanding.

Question 6

What is Artemisia argyi used for in traditional Chinese medicine?

Accepted Answer

Artemisia argyi is extensively used in traditional Chinese medicine for moxibustion therapy, where burning mugwort warms acupuncture points to stimulate circulation and promote healing. Internally, it serves as a warming digestive remedy for cold-type digestive complaints and as a menstrual regulator for irregular or painful periods. Its hemostatic properties make it valuable for stopping excessive bleeding. The herb is classified as warming and bitter, addressing cold stagnation patterns. These uses are supported by extensive traditional documentation (Level C evidence) rather than modern clinical trials.

Artemisia Argyi

Sources et citations

Résumé

Contexte

Usages traditionnels

Composés actifs

Mécanisme d'action

Preuves cliniques

Sécurité et effets indésirables

Synthèse des preuves

Sources PubMed

Sources gouvernementales